BIOATLA, INC. Total Shareholder Rtn Amt
BIOATLA, INC. (BCAB) reported Total Shareholder Rtn Amt of $6.88 for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-06-03.
Financial Statements › Notes
ecd:TotalShareholderRtnAmt · last filed 2026-06-03
| Period end | Total Shareholder Rtn Amt 12 month |
|---|---|
| 2025-12-31 | $6.88 DEF 14A · filed 2026-06-03 |
| 2024-12-31 | $7.17 DEF 14A · filed 2026-06-03 |
| 2023-12-31 | $29.82 DEF 14A · filed 2026-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |